4.8 Article

A tunable silk-alginate hydrogel scaffold for stem cell culture and transplantation

期刊

BIOMATERIALS
卷 35, 期 12, 页码 3736-3743

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2014.01.029

关键词

Silk; Alginate; Laminin; Scaffold; Stem cells; Elasticity

资金

  1. Howard Hughes Medical Institute (HHMI
  2. Fulbright Science and Technology Fellowship
  3. Stanford Weiland Fellowship
  4. Society for Nuclear Medicine (SNM)
  5. NIH NCI Center for Cancer Nanotechnology Excellence [CCNE U54 CA119367, CCNE U54 U54CA151459]

向作者/读者索取更多资源

One of the major challenges in regenerative medicine is the ability to recreate the stem cell niche, which is defined by its signaling molecules, the creation of cytokine gradients, and the modulation of matrix stiffness. A wide range of scaffolds has been developed in order to recapitulate the stem cell niche, among them hydrogels. This paper reports the development of a new silk-alginate based hydrogel with a focus on stem cell culture. This biocomposite allows to fine tune its elasticity during cell culture, addressing the importance of mechanotransduction during stem cell differentiation. The silk alginate scaffold promotes adherence of mouse embryonic stem cells and cell survival upon transplantation. In addition, it has tunable stiffness as function of the silk alginate ratio and the concentration of crosslinker a characteristic that is very hard to accomplish in current hydrogels. The hydrogel and the presented results represents key steps on the way of creating artificial stem cell niche, opening up new paths in regenerative medicine. (C) 2014 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Dermatology

Systemic minoxidil for hair disorders in pediatric patients: a safety and tolerability review

Jared M. John, Rodney D. Sinclair

Summary: Topical minoxidil has long been used to treat adult alopecia, and there is increasing evidence supporting the off-label use of low-dose oral minoxidil for this condition. However, little is known about its use in pediatric patients, and there are no established treatment guidelines. A retrospective review of 63 pediatric patients aged 0-12 years who were treated with low-dose oral or sublingual minoxidil showed that both treatments were generally well-tolerated, with mild hypertrichosis being the most commonly reported adverse event. Further research is needed to determine the effectiveness and optimal dosage of systemic minoxidil for treating alopecia in children.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2023)

Editorial Material Dermatology

Signposts to the Promised Land in Alopecia Areata

Dmitri Wall, Huw Rees, Laita Bokhari, Nekma Meah, Katherine York, Rodney Sinclair

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Article Biochemistry & Molecular Biology

Membrane-acting biomimetic peptoids against visceral leishmaniasis

Vivek Kumar, Jennifer S. Lin, Natalia Molchanova, John A. Fortkort, Carolin Reckmann, Stefan Braese, Havard Jenssen, Annelise E. Barron, Archana Chugh

Summary: Visceral leishmaniasis (VL) is a neglected tropical disease and the use of cell-permeating peptides as potential drug candidates to treat VL is limited due to their limited biological stability. In this study, peptoids, which are peptide mimics with good biostability, were tested against Leishmania donovani. The addition of N-alkyl hydrophobic chains and bromination yielded compounds with good antileishmanial activity against both intracellular amastigotes and promastigotes, indicating the potential of these peptoids as drug candidates for VL.

FEBS OPEN BIO (2023)

Article Microbiology

Tropodithietic Acid, a Multifunctional Antimicrobial, Facilitates Adaption and Colonization of the Producer, Phaeobacter piscinae

Laura Louise Lindqvist, Scott A. Jarmusch, Eva C. Sonnenschein, Mikael Lenz Strube, Janie Kim, Maike Wennekers Nielsen, Paul J. Kempen, Erwin M. Schoof, Sheng-Da Zhang, Lone Gram

Summary: The antibiotic tropodithietic acid (TDA) produced by bacteria affects multiple phenotypes and plays a key role in coordinating the colonization process of the producer. TDA has diverse effects on motility, cell morphology, metal metabolism, and horizontal gene transfer systems. This study broadens our understanding of the ecological role that secondary metabolites have in microbial community dynamics.

MSPHERE (2023)

Review Pharmacology & Pharmacy

An evaluation of the available pharmacotherapy for the treatment of hirsutism

Leila Asfour, Ahmed Kazmi, Rodney Sinclair

Summary: Hirsutism is a common condition in women characterized by excessive body hair in a male pattern distribution. It can cause significant psychological and social distress. Treatment options include combined oral contraceptive pills as first-line therapy, with the addition of oral antiandrogens for severe cases. Physical therapies and psychological support are important components of the management.

EXPERT OPINION ON PHARMACOTHERAPY (2023)

Article Dermatology

A randomized, double-blind, placebo- controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata

Cheng Zhou, Xiumin Yang, Bin Yang, Guofu Yan, Xiuqin Dong, Yangfeng Ding, Weixin Fan, Linfeng Li, Dingquan Yang, Hong Fang, Chao Ji, Hao Cheng, Shoumin Zhang, Aik Han Goh, Rongjun Liu, Xiaoyu Gu, Zaili Weng, Peter Foley, Rodney Sinclair, Jianzhong Zhang

Summary: This study evaluated the efficacy and safety of ivarmacitinib in patients with AA. The results showed that ivarmacitinib at doses of 4 and 8 mg was effective and generally well-tolerated in patients with moderate and severe AA for 24 weeks.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)

Article Medicine, General & Internal

Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial

Brett King, Xingqi Zhang, Walter Gubelin Harcha, Jacek C. Szepietowski, Jerry Shapiro, Charles Lynde, Natasha A. Mesinkovska, Samuel H. Zwillich, Lynne Napatalung, Dalia Wajsbrot, Rana Fayyad, Amy Freyman, Debanjali Mitra, Vivek Purohit, Rodney Sinclair, Robert Wolk

Summary: This study investigated the efficacy and safety of Ritlecitinib, an oral medication, in patients with alopecia areata. The findings showed that Ritlecitinib had good efficacy and tolerability in patients aged 12 years and older with alopecia areata, making it a suitable treatment option for those who require systemic therapy.

LANCET (2023)

Article Neurosciences

The anti-inflammatory effects of photobiomodulation are mediated by cytokines: Evidence from a mouse model of inflammation

Shirin Shamloo, Erwin Defensor, Peter Ciari, Gaku Ogawa, Laura Vidano, Jennifer S. Lin, John A. Fortkort, Mehrdad Shamloo, Annelise E. Barron

Summary: Photobiomodulation (PBM) is a safe therapeutic approach using specific wavelengths of light to prevent or limit neuroinflammatory processes and neuronal degeneration. In a study on mice, PBM was found to have anti-inflammatory effects by downregulating proinflammatory cytokines and upregulating anti-inflammatory cytokines, resulting in reducing LPS-induced peripheral and central inflammation. This study demonstrates the potential of PBM as an effective anti-inflammatory treatment.

FRONTIERS IN NEUROSCIENCE (2023)

Article Chemistry, Multidisciplinary

Real-Time Monitoring of Multitarget Antimicrobial Mechanisms of Peptoids Using Label-Free Imaging with Optical Diffraction Tomography

Minsang Kim, Yeongmi Cheon, Dongmin Shin, Jieun Choi, Josefine Eilso Nielsen, Myeong Seon Jeong, Ho Yeon Nam, Sung-Hak Kim, Reidar Lund, Havard Jenssen, Annelise E. Barron, Seongsoo Lee, Jiwon Seo

Summary: Antimicrobial peptides (AMPs) are effective against multidrug-resistant bacteria, and peptoids with N-substituted glycine backbone have also shown promise as antimicrobials. This study investigates the structure-activity relationship (SAR) of a library of peptoids and demonstrates that both membrane disruption and intracellular biomass flocculation are important mechanisms of bacterial killing.

ADVANCED SCIENCE (2023)

Article Biotechnology & Applied Microbiology

Rewiring the respiratory pathway of Lactococcus lactis to enhance extracellular electron transfer

Liuyan Gu, Xinxin Xiao, Ge Zhao, Paul Kempen, Shuangqing Zhao, Jianming Liu, Sang Yup Lee, Christian Solem

Summary: This study demonstrates for the first time that Lactococcus lactis, a lactic acid bacterium, can use ferricyanide as an alternative electron acceptor to support growth. By analyzing mutants and conducting electrochemical analysis, the essential role of NADH dehydrogenase and 2-amino-3-carboxy-1,4-naphtoquinone in extracellular electron transfer is identified and the underlying pathway is systematically uncovered. The study also reveals the unexpected effects of ferricyanide respiration on L. lactis, including changes in morphology and increased acid resistance.

MICROBIAL BIOTECHNOLOGY (2023)

Article Dermatology

Incidence and prevalence of alopecia areata in the Australian primary care setting: A retrospective analysis of electronic health record data

R. Sinclair, S. Eisman, W. Song, B. Heung, C. Surian, C. M. Y. Lee, D. Witcombe

Summary: This study provides the first description of the epidemiology (incidence and point prevalence) and management of alopecia areata (AA) in the Australian primary health-care population through large-scale database analysis. The incidence and prevalence findings were consistent with earlier estimates from other regions.

AUSTRALASIAN JOURNAL OF DERMATOLOGY (2023)

Article Dermatology

When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials

Brett King, Jerry Shapiro, Manabu Ohyama, Alexander Egeberg, Bianca Maria Piraccini, Brittany Craiglow, Rodney Sinclair, Yun-Fei Chen, Wen-Shuo Wu, Yuxin Ding, Najwa Somani, Yves Dutronc

Summary: Different clinical response subgroups can be identified in baricitinib-treated patients with severe alopecia areata, and these subgroups are influenced by baseline characteristics. The findings from these analyses will help in understanding treatment expectations for scalp hair regrowth.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Article Immunology

A plain language summary on ritlecitinib treatment for adults and adolescents with alopecia areata

Brett King, Xingqi Zhang, Walter Gubelin Harcha, Jacek C. Szepietowski, Jerry Shapiro, Charles Lynde, Natasha A. Mesinkovska, Samuel H. Zwillich, Lynne Napatalung, Dalia Wajsbrot, Rana Fayyad, Amy Freyman, Debanjali Mitra, Vivek Purohit, Rodney Sinclair, Robert Wolk

Summary: This is a summary of the results of the ALLEGRO-2b/3 clinical trial, which investigated the effectiveness and safety of ritlecitinib in treating alopecia areata. The study found that ritlecitinib promoted hair regrowth in AA patients and demonstrated good tolerability over the course of 48 weeks.

IMMUNOTHERAPY (2023)

Article Chemistry, Medicinal

Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity

Patrick M. Tate, Vincent Mastrodomenico, Christina Cunha, Joshua McClure, Annelise E. Barron, Gill Diamond, Bryan C. Mounce, Kent Kirshenbaum

Summary: The development of durable new antiviral therapies is challenging due to rapid virus evolution and resistance. Peptoids, a family of AMP mimetics, show direct antiviral activity against enveloped viruses by disrupting viral membrane constituents. These findings suggest that peptoids have the potential to be a new family of therapeutics capable of preventing resistance.

ACS INFECTIOUS DISEASES (2023)

Meeting Abstract Dermatology

Individual SALT score trajectories of de novo patients with alopecia areata (AA) treated with ritlecitinib in the ongoing phase 3, long-term, open-label ALLEGRO-LT study

B. King, P. Mirmirani, K. Lo Sicco, Y. Ramot, R. Sinclair, R. Edwards, U. Kerkmann, D. Wajsbrot, S. Zwillich, A. Lejeune

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Article Engineering, Biomedical

A novel capsid-XL32-derived adeno-associated virus serotype prompts retinal tropism and ameliorates choroidal neovascularization

Lin-Lin Luo, Jie Xu, Bing-Qiao Wang, Chen Chen, Xi Chen, Qiu-Mei Hu, Yu-Qiu Wang, Wan-Yun Zhang, Wan-Xiang Jiang, Xin-Ting Li, Hu Zhou, Xiao Xiao, Kai Zhao, Sen Lin

Summary: A novel AAV serotype, AAVYC5, introduced in this study, showed more efficient transduction into multiple retinal layers compared to AAV2, and enabled successful delivery of anti-angiogenic molecules in mice and non-human primates.

BIOMATERIALS (2024)